Table 3 Reporting of essential information
Reporting of essential information | N = 77 (%) |
|---|---|
Study characteristics | |
 - Specification of the target trial | 2 (3) |
 - Using a diagram to illustrate study design | 14 (18) |
Eligibility criteria | |
 - Inclusion criteria for the study | 76 (99) |
 - Post-baseline events in inclusion criteria (e.g., use of treatment, no follow-up data) | 9 (12) |
 - Exclusion of individuals with contraindications for interventions evaluated | 9 (12) |
Adjustment for confounders | |
 - Propensity score | 60 (70) |
 - Inverse probability weighting | 10 (12) |
 - Multivariable regression | 15 (17) |
 - Instrumental variable | 2 (2) |
Outcome | |
 - Primary outcome reported | 77 (100) |
Causal contrast of interests | |
 - Intention-to-treat effect | 11 (14) |
 - Per-protocol effect | 6 (8) |
 - Both | 10 (13) |
 - Not specified | 50 (65) |
Key time point of the target trial | |
 - Time point of the start of follow-up | 72 (94) |
 - Time point of eligibility criteria | 72 (94) |
 - Time point of treatment assignment | 68 (88) |
 - All three time points | 63 (81) |